AT1 3.85% 2.7¢ atomo diagnostics limited

Ann: Appendix 4C - 31 December 2021, page-4

  1. 14 Posts.
    lightbulb Created with Sketch. 6
    Would like to see the details that come out of the Investor Briefing, before judging too much. From the Appendix4C it looks like a fairly big jump on the last quarter for administration and corporate costs, and a fairly insignificant sum spent on marketing. Understand they have self marketed a bit through news interviews etc and have been selling b2b but $9000..... seems quite paltry when they are selling HIV tests direct to the public. A more positive view would be they are saving using partner organisations to move product but a breakdown of where sales are coming from would be nice.










    These are my views/opinions only please do your own research
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $16.61M
Open High Low Value Volume
2.5¢ 2.7¢ 2.5¢ $13.81K 531.9K

Buyers (Bids)

No. Vol. Price($)
2 319327 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 158224 3
View Market Depth
Last trade - 14.37pm 09/07/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.